Dozens of lawsuits filed against makers of Ozempic, Wegovy and Zepbound over rare vision loss, ABC News reports

Dozens of lawsuits have been filed against the companies behind the popular GLP-1 drugs Ozempic, Wegovy and Zepbound, alleging the drugs caused a rare type of vision loss, ABC News reports.

Detected & updated continuously · Source: Nebula

Story subjects

OzempicWegovyZepboundABC News

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula